Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Top Dividend Stocks To Enhance Your Portfolio

In This Article:

As global markets experience broad-based gains with U.S. indexes approaching record highs and economic indicators like initial jobless claims reaching new lows, investors are closely monitoring the Federal Reserve's upcoming decisions on interest rates. In this dynamic environment, dividend stocks stand out as a compelling option for enhancing portfolios, offering potential income stability amid market fluctuations and geopolitical uncertainties.

Top 10 Dividend Stocks

Name

Dividend Yield

Dividend Rating

Guaranty Trust Holding (NGSE:GTCO)

6.98%

★★★★★★

Peoples Bancorp (NasdaqGS:PEBO)

4.54%

★★★★★★

Tsubakimoto Chain (TSE:6371)

4.26%

★★★★★★

CAC Holdings (TSE:4725)

4.62%

★★★★★★

Padma Oil (DSE:PADMAOIL)

6.60%

★★★★★★

Financial Institutions (NasdaqGS:FISI)

4.46%

★★★★★★

James Latham (AIM:LTHM)

6.73%

★★★★★★

Citizens & Northern (NasdaqCM:CZNC)

5.56%

★★★★★★

Premier Financial (NasdaqGS:PFC)

4.45%

★★★★★★

Banque Cantonale Vaudoise (SWX:BCVN)

4.93%

★★★★★★

Click here to see the full list of 1964 stocks from our Top Dividend Stocks screener.

Let's review some notable picks from our screened stocks.

China Medical System Holdings

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: China Medical System Holdings Limited is an investment holding company that manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China with a market cap of HK$18.66 billion.

Operations: The company's revenue segment primarily comprises CN¥7.01 billion from the marketing, promotion, sales, and manufacturing of pharmaceutical products in China.

Dividend Yield: 5.4%

China Medical System Holdings offers a dividend yield of 5.38%, which is modest compared to top-tier Hong Kong dividend payers. The company's payout ratio is 40.3%, suggesting dividends are covered by earnings, though cash flow coverage is tighter at 76.6%. Despite past volatility and unreliability in dividends, recent product approvals could enhance future stability and growth potential, especially with the NMPA's approval of CMS-D005 for clinical trials in China.

SEHK:867 Dividend History as at Nov 2024
SEHK:867 Dividend History as at Nov 2024

Runner (Xiamen)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Runner (Xiamen) Corp. is involved in the R&D, design, production, and sale of kitchen and bathroom products as well as water purification products both in China and internationally, with a market cap of CN¥5.76 billion.